4//SEC Filing
Farid Ramy 4
Accession 0001628280-24-025999
CIK 0001706431other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 2:43 PM ET
Size
8.9 KB
Accession
0001628280-24-025999
Insider Transaction Report
Form 4
Farid Ramy
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-05-29+16,000→ 16,000 totalExercise: $10.10Exp: 2034-05-28→ Common Stock (16,000 underlying) - Award
Stock Option (Right to Buy)
2024-05-29+16,000→ 16,000 totalExercise: $10.10Exp: 2034-05-28→ Common Stock (16,000 underlying) - Award
Common Stock
2024-05-29+16,000→ 16,000 total
Footnotes (2)
- [F1]1/3 of the shares subject to the stock option vest and become exercisable on May 29, 2025, and the remaining shares vest in 24 equal monthly installments thereafter.
- [F2]Shares subject to the stock option vest and become exercisable on the earlier of (i) May 29, 2025, or (i) the date of the Company's next annual meeting of stockholders.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001797707
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 2:43 PM ET
- Size
- 8.9 KB